Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic dysfunction–associated steatotic liver disease.

Metabolic dysfunction–associated steatohepatitis (MASH) is a form of liver disease that can progress ... to evaluate the GLP-1 receptor agonist semaglutide in patients with MASH and stage ...

"Whereas semaglutide works by activating receptors ... we will choose the GLP-1 that is proven to work best for liver disease," she said. Looking ahead, the researchers plan to investigate new ...

Discover a recent study where the authors propose a strategic push to double the diagnostic rate of at-risk MASH by 2030.

India is facing a silent epidemic of non-alcoholic fatty liver disease, especially affecting young people. Around 1 to 3 ...

A South Korean biotech’s GLP-1 candidate has reduced liver fat in patients with metabolic dysfunction-associated ...

In this retrospective cohort study, treatment with semaglutide resulted in nominally lower incidence of the composite of ...

Londono said these treatments can come with side effects. Semaglutide Found To Have Shocking Benefit For Liver Disease Patients In New Study "Most people on these medications only report mild symptoms ...